Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Mar;78(3):222–229. doi: 10.1136/adc.78.3.222

Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment

R Postlethwaite 1, D Eminson 1, J Reynolds 1, A Wood 1, S Hollis 1
PMCID: PMC1717494  PMID: 9613351

Abstract

Growth and psychological functioning were studied in 30 patients with renal failure over a two year period following the offer of growth hormone treatment for significant short stature. Parents' concerns about growth decreased significantly during the study. Twenty eight parents (93%) accepted growth hormone treatment; most (74%) were satisfied with it and would opt for it again (89%). The views of these parents were unrelated to growth outcome in their child. This suggests that the positive responses were related more to the effort to improve growth than to any objective treatment success. In contrast children's reduction in concern about growth, satisfaction with treatment (36%), and decision to opt for growth hormone again (50%) were all significantly related to improvement in growth. Parents' reports of non-compliance increased significantly from 41% at 1 year to 91% at 2 years in the group as a whole. No significant changes were identified in maternal mental distress and no additional costs to the psychological health of the children seem to have resulted from the introduction of growth hormone treatment. A group of children was identified who accepted treatment but had continued poor growth. These appeared to be at particular risk of both physical problems and associated or consequent psychological difficulties.



Full Text

The Full Text of this article is available as a PDF (138.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck D. E., Fennell R. S., Yost R. L., Robinson J. D., Geary D., Richards G. A. Evaluation of an educational program on compliance with medication regimens in pediatric patients with renal transplants. J Pediatr. 1980 Jun;96(6):1094–1097. doi: 10.1016/s0022-3476(80)80653-6. [DOI] [PubMed] [Google Scholar]
  2. Costello E. J., Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):726–737. doi: 10.1097/00004583-198811000-00011. [DOI] [PubMed] [Google Scholar]
  3. Downie A. B., Mulligan J., Stratford R. J., Betts P. R., Voss L. D. Are short normal children at a disadvantage? The Wessex growth study. BMJ. 1997 Jan 11;314(7074):97–100. doi: 10.1136/bmj.314.7074.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ettenger R. B., Rosenthal J. T., Marik J. L., Malekzadeh M., Forsythe S. B., Kamil E. S., Salusky I. B., Fine R. N. Improved cadaveric renal transplant outcome in children. Pediatr Nephrol. 1991 Jan;5(1):137–142. doi: 10.1007/BF00852871. [DOI] [PubMed] [Google Scholar]
  5. Fine R. N., Kohaut E. C., Brown D., Perlman A. J. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr. 1994 Mar;124(3):374–382. doi: 10.1016/s0022-3476(94)70358-2. [DOI] [PubMed] [Google Scholar]
  6. Fine R. N., Kohaut E., Brown D., Kuntze J., Attie K. M. Long-term treatment of growth retarded children with chronic renal insufficiency, with recombinant human growth hormone. Kidney Int. 1996 Mar;49(3):781–785. doi: 10.1038/ki.1996.108. [DOI] [PubMed] [Google Scholar]
  7. Fine R. N. Pathophysiology of growth retardation in children with chronic renal failure. J Pediatr Endocrinol. 1994 Apr-Jun;7(2):79–83. doi: 10.1515/jpem.1994.7.2.79. [DOI] [PubMed] [Google Scholar]
  8. Frisch H., Häusler G., Lindenbauer S., Singer S. Psychological aspects in children and adolescents with hypopituitarism. Acta Paediatr Scand. 1990 Jun-Jul;79(6-7):644–651. doi: 10.1111/j.1651-2227.1990.tb11529.x. [DOI] [PubMed] [Google Scholar]
  9. Gagnadoux M. F., Niaudet P., Broyer M. Non-immunological risk factors in paediatric renal transplantation. Pediatr Nephrol. 1993 Feb;7(1):89–95. doi: 10.1007/BF00861586. [DOI] [PubMed] [Google Scholar]
  10. Garralda M. E., Jameson R. A., Reynolds J. M., Postlethwaite R. J. Psychiatric adjustment in children with chronic renal failure. J Child Psychol Psychiatry. 1988 Jan;29(1):79–90. doi: 10.1111/j.1469-7610.1988.tb00691.x. [DOI] [PubMed] [Google Scholar]
  11. Goh D., Evans J. H., Houston I. B., Mallick N. P., Morton M. J., Johnson R. W., Postlethwaite R. J. The changing pattern of children's dialysis and transplantation over 20 years. Clin Nephrol. 1994 Oct;42(4):227–231. [PubMed] [Google Scholar]
  12. Goldberg D. P., Hillier V. F. A scaled version of the General Health Questionnaire. Psychol Med. 1979 Feb;9(1):139–145. doi: 10.1017/s0033291700021644. [DOI] [PubMed] [Google Scholar]
  13. Hokken-Koelega A. C., Stijnen T., de Jong R. C., Donckerwolcke R. A., Groothoff J. W., Wolff E. D., Blum W. F., de Muinck Keizer-Schrama S. M., Drop S. L. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney Int Suppl. 1996 Jan;53:S128–S134. [PubMed] [Google Scholar]
  14. Hokken-Koelega A. C., Stijnen T., de Muinck Keizer-Schrama S. M., Wit J. M., Wolff E. D., de Jong M. C., Donckerwolcke R. A., Abbad N. C., Bot A., Blum W. F. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet. 1991 Sep 7;338(8767):585–590. doi: 10.1016/0140-6736(91)90604-n. [DOI] [PubMed] [Google Scholar]
  15. Ito K., Kawaguchi H. Treatment of uremic children in Japan with recombinant human growth hormone (rhGH). Japanese Multi-Center Open Study Group on Children with Renal Disease. J Pediatr Endocrinol. 1994 Apr-Jun;7(2):115–118. doi: 10.1515/jpem.1994.7.2.115. [DOI] [PubMed] [Google Scholar]
  16. Kohaut E. C., Tejani A. The 1994 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1996 Aug;10(4):422–434. doi: 10.1007/s004670050132. [DOI] [PubMed] [Google Scholar]
  17. Kusalic M., Fortin C. Growth hormone treatment in hypopituitary dwarfs: longitudinal psychological effects. Can Psychiatr Assoc J. 1975 Aug;20(5):325–331. doi: 10.1177/070674377502000501. [DOI] [PubMed] [Google Scholar]
  18. Maxwell H., Rees L. Recombinant human growth hormone treatment in infants with chronic renal failure. Arch Dis Child. 1996 Jan;74(1):40–43. doi: 10.1136/adc.74.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mehls O., Broyer M. Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. The European/Australian Study Group. Acta Paediatr Suppl. 1994 Apr;399:81–87. doi: 10.1111/j.1651-2227.1994.tb13299.x. [DOI] [PubMed] [Google Scholar]
  20. Mehls O., Ritz E. Skeletal growth in experimental uremia. Kidney Int Suppl. 1983 Nov;15:S53–S62. [PubMed] [Google Scholar]
  21. Postlethwaite R. J., Reynolds J. M., Wood A. J., Evans J. H., Lewis M. A., Eminson D. M. Recruiting patients to clinical trials: lessons from studies of growth hormone treatment in renal failure. Arch Dis Child. 1995 Jul;73(1):30–35. doi: 10.1136/adc.73.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Reynolds J. M., Garralda M. E., Jameson R. A., Postlethwaite R. J. How parents and families cope with chronic renal failure. Arch Dis Child. 1988 Jul;63(7):821–826. doi: 10.1136/adc.63.7.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Reynolds J. M., Garralda M. E., Jameson R. A., Postlethwaite R. J. Living with chronic renal failure. Child Care Health Dev. 1986 Nov-Dec;12(6):401–407. doi: 10.1111/j.1365-2214.1986.tb00517.x. [DOI] [PubMed] [Google Scholar]
  24. Reynolds J. M., Wood A. J., Eminson D. M., Postlethwaite R. J. Short stature and chronic renal failure: what concerns children and parents? Arch Dis Child. 1995 Jul;73(1):36–42. doi: 10.1136/adc.73.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rotnem D., Cohen D. J., Hintz R., Genel M. Psychological sequelae of relative "treatment failure" for children receiving human growth hormone replacement. J Am Acad Child Psychiatry. 1979 Summer;18(3):505–520. doi: 10.1097/00004583-197922000-00008. [DOI] [PubMed] [Google Scholar]
  26. Smith S. L., Hindmarsh P. C., Brook C. G. Compliance with growth hormone treatment--are they getting it? Arch Dis Child. 1993 Jan;68(1):91–93. doi: 10.1136/adc.68.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Voss L. D., Wiklund I. Short stature and psychosocial assessment. Acta Paediatr Suppl. 1995 Sep;411:69–74. doi: 10.1111/j.1651-2227.1995.tb13868.x. [DOI] [PubMed] [Google Scholar]
  28. Warady B. A., Hébert D., Sullivan E. K., Alexander S. R., Tejani A. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1997 Feb;11(1):49–64. doi: 10.1007/s004670050232. [DOI] [PubMed] [Google Scholar]
  29. Wood A., Kroll L., Moore A., Harrington R. Properties of the mood and feelings questionnaire in adolescent psychiatric outpatients: a research note. J Child Psychol Psychiatry. 1995 Feb;36(2):327–334. doi: 10.1111/j.1469-7610.1995.tb01828.x. [DOI] [PubMed] [Google Scholar]
  30. Wühl E., Haffner D., Nissel R., Schaefer F., Mehls O. Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol. 1996 Jun;10(3):294–298. doi: 10.1007/BF00866763. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES